Management of tinea capitis in infants and children in the United States: A national survey of pediatric dermatologists.
Pediatr Dermatol
; 41(2): 263-265, 2024.
Article
en En
| MEDLINE
| ID: mdl-38342578
ABSTRACT
This study aimed to evaluate the current management of tinea capitis in the United States, specifically focusing on patients aged 0-2 months, 2 months to 2 years, and 2 years to 18 years. An online survey, distributed through the Pediatric Dermatology Research Alliance and the Society of Pediatric Dermatology, revealed the following preferences fluconazole for those under 2 months, griseofulvin for those aged 2 months to 2 years, and terbinafine for those aged 2 years and older. There exists inter-provider variation in tinea capitis treatment regimens within the pediatric dermatology community.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Tiña del Cuero Cabelludo
/
Antifúngicos
Límite:
Child
/
Humans
/
Infant
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Pediatr Dermatol
/
Pediatr. dermatol
/
Pediatric dermatology
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos